| 摘要 |
Crystalline 3-Ä(1S)-1-(2-fluorobiphenyl-4-yl)ethylÜ-5-äÄamino(morpholin-4-yl)methyleneÜaminoü-isoxazole that exhibits the following angle of diffraction (2&thetas;) and relative intensity in a powder X-ray diffraction pattern, is very easy to handle and stable in a process of its formulation into a pharmaceutical preparation. <TABLE> |
